This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University Technology Corporation. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Dylan J Taatjes
Introduction
Dylan J Taatjes is a notable inventor based in Boulder, CO (US). He has made significant strides in the field of pharmaceuticals, particularly in the development of anti-cancer drugs. His work focuses on enhancing the efficacy of cancer treatments through innovative drug formulations.
Latest Patents
Dylan J Taatjes holds a patent for "Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositions and methods." This patent includes monomeric and dimeric anti-cancer drug aldehyde conjugate compounds and pharmaceutically acceptable salts thereof. Specifically, it provides monomeric and dimeric aldehyde conjugates of 1-2, dihetero-substituted anti-cancer drugs, including anthracyclines. The patent also discusses pro-drugs that release monomeric aldehyde conjugates after administration. Furthermore, it outlines pharmaceutical and therapeutic compositions containing these anti-cancer drug aldehyde conjugates and methods for treating cancer using them.
Career Highlights
Dylan J Taatjes is associated with University Technology Corporation, where he continues to contribute to research and development in the pharmaceutical sector. His innovative approach to drug design has positioned him as a key figure in the fight against cancer.
Collaborations
Dylan collaborates with esteemed colleagues such as Tad H Koch and David J Fenick. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Dylan J Taatjes exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to anti-cancer drug development are paving the way for more effective treatments.